| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,761 |
9,040 |
$607K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,065 |
4,465 |
$432K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,855 |
1,852 |
$126K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
551 |
536 |
$48K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
818 |
765 |
$34K |
| 99215 |
Prolong outpt/office vis |
299 |
286 |
$30K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
224 |
224 |
$26K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
176 |
171 |
$16K |
| 86328 |
|
550 |
485 |
$15K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
850 |
678 |
$14K |
| 36415 |
Collection of venous blood by venipuncture |
2,573 |
2,468 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
171 |
161 |
$6K |
| 99443 |
|
39 |
38 |
$4K |
| 99442 |
|
47 |
46 |
$3K |
| 99000 |
|
632 |
601 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
199 |
198 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
211 |
201 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
29 |
29 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12 |
12 |
$1K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
525 |
344 |
$723.30 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14 |
14 |
$486.85 |
| 81002 |
|
160 |
157 |
$422.29 |
| 90756 |
|
16 |
16 |
$387.80 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
36 |
35 |
$346.92 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
43 |
33 |
$319.06 |
| 99406 |
|
15 |
12 |
$124.64 |
| 96127 |
|
42 |
42 |
$108.16 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14 |
13 |
$88.44 |
| 83037 |
|
15 |
15 |
$88.44 |
| 81025 |
|
12 |
12 |
$78.43 |
| 82044 |
|
17 |
17 |
$67.08 |
| 83013 |
|
12 |
12 |
$50.00 |
| 81001 |
|
17 |
17 |
$39.30 |
| 81003 |
|
25 |
25 |
$29.92 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12 |
12 |
$17.74 |
| 1159F |
|
372 |
344 |
$0.75 |
| 1160F |
|
418 |
373 |
$0.66 |
| 3077F |
|
49 |
43 |
$0.03 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
422 |
352 |
$0.00 |
| 3079F |
|
71 |
64 |
$0.00 |
| 3074F |
|
309 |
250 |
$0.00 |
| 0001F |
|
373 |
324 |
$0.00 |
| 3075F |
|
21 |
18 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
179 |
153 |
$0.00 |
| 3078F |
|
330 |
271 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
101 |
93 |
$0.00 |
| 99072 |
|
104 |
103 |
$0.00 |
| 4551F |
|
77 |
72 |
$0.00 |
| 3725F |
|
112 |
112 |
$0.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
18 |
17 |
$0.00 |